Advertisement
UK markets closed

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    83.01
    -0.35 (-0.42%)
     

  • GOLD FUTURES

    2,335.20
    -6.90 (-0.29%)
     

  • DOW

    38,500.84
    -2.85 (-0.01%)
     

  • Bitcoin GBP

    51,621.05
    -1,816.69 (-3.40%)
     

  • CMC Crypto 200

    1,386.25
    -37.85 (-2.66%)
     

  • NASDAQ Composite

    15,717.37
    +20.73 (+0.13%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

AstraZeneca's head of R&D for oncology dies at 61

Reuters
·1-min read

(Reuters) - AstraZeneca Plc's head of oncology research, Jose Baselga, has died at the age of 61, the company said on Sunday.

"An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca," the company's Chief Executive Officer Pascal Soriot said https://bit.ly/3lye6YU in a statement.

The statement did not give a cause of death but Spanish newspaper La Vanguardia said Baselga had died of Creutzfeldt-Jakob disease, a rare brain condition.

Baselga joined AstraZeneca in 2019. He previously worked as Memorial Sloan Kettering Cancer Center's chief medical officer. He had also been chief of hematology/oncology at the Massachusetts General Hospital Cancer Center and a professor at Harvard Medical School.

(Reporting by Radhika Anilkumar in Bengaluru; Editing by Frances Kerry)